Science Explorer Back to mapMap
Discussion

OsteoGeneX (United States)

Research works
2
fractional, all time
Citations
213
86.9 per fractional work
Top-10% rate
18.0%
all institutions 10.0%
Open access
90%
world 40%
International
10%
world 18%

Not ranked overall: OsteoGeneX (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does OsteoGeneX (United States) work in?

In all years, 96% of research at OsteoGeneX (United States) is in Life Sciences, 4% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (96%), Medicine (4%). It does 1.6× the world's share of Life Sciences.

Life Sciences96%Health Sciences4%

Each ring splits the one inside it: the four domains of science, their fields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 2 domains and 2 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology296.0%
    1. Medicine04.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What are the most cited papers from OsteoGeneX (United States)?

The most cited paper from OsteoGeneX (United States) is "Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity" (Debra L. Ellies, Beth L. Viviano, John Joseph McCarthy et al., 2006), with 355 citations. Next come "In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism" (136) and "Wnt modulators in the biotech pipeline" (71).

Most cited papers
#PaperReleasedCitations
1 Bone Density Ligand, Sclerostin, Directly Interacts With LRP5 but Not LRP5G171V to Modulate Wnt Activity Debra L. Ellies, Beth L. Viviano, John Joseph McCarthy et al. · Journal of Bone and Mineral Research Open access 29 Sep 2006 355
2 In vivo mechanical loading rapidly activates β-catenin signaling in osteocytes through a prostaglandin mediated mechanism Nuria Lara-Castillo, Nellie Kim-Weroha, Mohamed A. Kamel et al. · Bone Open access 5 Apr 2015 136
3 Wnt modulators in the biotech pipeline Jean‐Philippe Rey, Debra L. Ellies · Developmental Dynamics Open access 11 Dec 2009 71
All 3 most cited papers, with filters and sorting

Which research topics does OsteoGeneX (United States) publish most on?

By volume: Animal Genetics and Reproduction, Wnt/β-catenin signaling in development and cancer, Cancer-related gene regulation and Skin and Cellular Biology Research.

  1. 1 Animal Genetics and Reproduction Genetics 1 works
  2. 2 Wnt/β-catenin signaling in development and cancer Molecular Biology 0 works
  3. 3 Cancer-related gene regulation Molecular Biology 0 works
  4. 4 Skin and Cellular Biology Research Cell Biology 0 works
  5. 5 Bone Metabolism and Diseases Molecular Biology 0 works
  6. 6 Heat shock proteins research Molecular Biology 0 works
  7. 7 Bone health and osteoporosis research Orthopedics and Sports Medicine 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available89.8%not open10.2%

World: 40% of research is openly available.

with international co-authors10.2%domestic only89.8%

World: 18% is written across borders.

How has OsteoGeneX (United States)'s research output changed?

20102015

Other research institutions in Overland Park

All research institutions in Overland Park

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about OsteoGeneX (United States). Posts are plain text and can be reported.